HPV and Cervical Neoplasia in Women
Author Information
Author(s): Grainge M J, Seth R, Coupland C, Guo L, Rittman T, Vryenhoef P, Johnson J, Jenkins D, Neal K R
Primary Institution: University of Nottingham Medical School
Hypothesis
Can HPV testing predict the development of high-grade cervical intraepithelial neoplasia or cervical cancer in women?
Conclusion
The study found that HPV significantly predicts the development of high-grade cervical disease an average of 6.8 years later.
Supporting Evidence
- 27.0% of cases tested positive for HPV at baseline compared to 15.4% of controls.
- HPV+ women had a two-fold increase in the risk of developing an outcome lesion.
- For women aged 40 years or over, the odds ratio for HPV 16 was 8.95.
Takeaway
This study shows that women who test positive for HPV are more likely to develop serious cervical problems later on.
Methodology
A case-control study was conducted with 575 cases and 601 controls, using HPV testing on archived cervical smears.
Potential Biases
Potential misclassification of controls as disease-free could bias results.
Limitations
The study relied on archived smears, which may have resulted in underestimation of HPV infection rates.
Participant Demographics
Women aged under 20, 20-39, and 40 years or over, with a focus on older women.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI, 1.50–2.68
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website